Agile Biomedical Consultants has entered into a strategic agreement with Global Detian Life Sciences Technology (GDLST) Ltd, a Beijing-based biotechnology partner, for the joint development and manufacture of novel oncology therapeutics in China.
Under the agreement, we will draw on GDLST's R&D and manufacturing infrastructure to accelerate the discovery, optimisation and eventual production of new cancer drug candidates for indications with high unmet need.
The partnership expands our international footprint and gives us access to research talent, clinical trial networks and manufacturing capacity in China.